Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 275

1.

A simple structure-based model for the prediction of HIV-1 co-receptor tropism.

Heider D, Dybowski JN, Wilms C, Hoffmann D.

BioData Min. 2014 Aug 1;7:14. doi: 10.1186/1756-0381-7-14. eCollection 2014.

PMID:
25120583
[PubMed]
Free PMC Article
2.

Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection.

Raska M, Czernekova L, Moldoveanu Z, Zachova K, Elliott MC, Novak Z, Hall S, Hoelscher M, Maboko L, Brown R, Smith PD, Mestecky J, Novak J.

AIDS Res Ther. 2014 Aug 1;11:23. doi: 10.1186/1742-6405-11-23. eCollection 2014.

PMID:
25120578
[PubMed]
Free PMC Article
3.

Insight Derived from Molecular Dynamics Simulations into Molecular Motions, Thermodynamics and Kinetics of HIV-1 gp120.

Sang P, Yang LQ, Ji XL, Fu YX, Liu SQ.

PLoS One. 2014 Aug 8;9(8):e104714. doi: 10.1371/journal.pone.0104714. eCollection 2014.

PMID:
25105502
[PubMed - in process]
Free PMC Article
4.

Molecular characterization of HIV-1 subtype C gp-120 regions potentially involved in virus adaptive mechanisms.

Cenci A, D'Avenio G, Tavoschi L, Chiappi M, Becattini S, Narino Mdel P, Picconi O, Bernasconi D, Fanales-Belasio E, Vardas E, Sukati H, Lo Presti A, Ciccozzi M, Monini P, Ensoli B, Grigioni M, Buttò S.

PLoS One. 2014 Apr 30;9(4):e95183. doi: 10.1371/journal.pone.0095183. eCollection 2014.

PMID:
24788065
[PubMed - in process]
Free PMC Article
5.

Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop.

Tamamis P, Floudas CA.

PLoS One. 2014 Apr 24;9(4):e95767. doi: 10.1371/journal.pone.0095767. eCollection 2014.

PMID:
24763408
[PubMed - in process]
Free PMC Article
6.

Reversible and efficient activation of HIV-1 cell entry by a tyrosine-sulfated peptide dissects endocytic entry and inhibitor mechanisms.

Platt EJ, Gomes MM, Kabat D.

J Virol. 2014 Apr;88(8):4304-18. doi: 10.1128/JVI.03447-13. Epub 2014 Jan 29.

PMID:
24478426
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Natural Scrub Typhus Antibody Suppresses HIV CXCR4(X4) Viruses.

Watt G, Kantipong P, Burnouf T, Shikuma C, Philpott S.

Infect Dis Rep. 2013 May 15;5(1):e8. doi: 10.4081/idr.2013.e8. eCollection 2013 Jan 22. Review.

PMID:
24470959
[PubMed]
Free PMC Article
8.

Critical amino acids within the human immunodeficiency virus type 1 envelope glycoprotein V4 N- and C-terminals contribute to virus entry.

Li Y, Yang D, Wang JY, Yao Y, Zhang WZ, Wang LJ, Cheng DC, Yang FK, Zhang FM, Zhuang M, Ling H.

PLoS One. 2014 Jan 21;9(1):e86083. doi: 10.1371/journal.pone.0086083. eCollection 2014.

PMID:
24465884
[PubMed - in process]
Free PMC Article
9.

Reply to Subramaniam, van Heel, and Henderson: Validity of the cryo-electron microscopy structures of the HIV-1 envelope glycoprotein complex.

Mao Y, Castillo-Menendez LR, Sodroski JG.

Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):E4178-82. No abstract available.

PMID:
24350339
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition.

Connell BJ, Lortat-Jacob H.

Front Immunol. 2013 Nov 20;4:385. doi: 10.3389/fimmu.2013.00385. Review.

PMID:
24312095
[PubMed]
Free PMC Article
11.

The influence of N-linked glycans on the molecular dynamics of the HIV-1 gp120 V3 loop.

Wood NT, Fadda E, Davis R, Grant OC, Martin JC, Woods RJ, Travers SA.

PLoS One. 2013 Nov 26;8(11):e80301. doi: 10.1371/journal.pone.0080301. eCollection 2013.

PMID:
24303005
[PubMed - in process]
Free PMC Article
12.

Modelling binding between CCR5 and CXCR4 receptors and their ligands suggests the surface electrostatic potential of the co-receptor to be a key player in the HIV-1 tropism.

Kalinina OV, Pfeifer N, Lengauer T.

Retrovirology. 2013 Nov 11;10:130. doi: 10.1186/1742-4690-10-130.

PMID:
24215935
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Genetic diversity of the highly variable V1 region interferes with Human Immunodeficiency Virus type 1 envelope functionality.

Hamoudi M, Simon-Loriere E, Gasser R, Negroni M.

Retrovirology. 2013 Oct 24;10:114. doi: 10.1186/1742-4690-10-114.

PMID:
24156625
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Prefusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy.

Bartesaghi A, Merk A, Borgnia MJ, Milne JL, Subramaniam S.

Nat Struct Mol Biol. 2013 Dec;20(12):1352-7. doi: 10.1038/nsmb.2711. Epub 2013 Oct 23.

PMID:
24154805
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Stabilizing exposure of conserved epitopes by structure guided insertion of disulfide bond in HIV-1 envelope glycoprotein.

Kassa A, Dey AK, Sarkar P, Labranche C, Go EP, Clark DF, Sun Y, Nandi A, Hartog K, Desaire H, Montefiori D, Carfi A, Srivastava IK, Barnett SW.

PLoS One. 2013 Oct 16;8(10):e76139. doi: 10.1371/journal.pone.0076139. eCollection 2013.

PMID:
24146829
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk.

Fouda GG, Jaeger FH, Amos JD, Ho C, Kunz EL, Anasti K, Stamper LW, Liebl BE, Barbas KH, Ohashi T, Moseley MA, Liao HX, Erickson HP, Alam SM, Permar SR.

Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18220-5. doi: 10.1073/pnas.1307336110. Epub 2013 Oct 21.

PMID:
24145401
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial.

Gottardo R, Bailer RT, Korber BT, Gnanakaran S, Phillips J, Shen X, Tomaras GD, Turk E, Imholte G, Eckler L, Wenschuh H, Zerweck J, Greene K, Gao H, Berman PW, Francis D, Sinangil F, Lee C, Nitayaphan S, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, Tartaglia J, Robb ML, Michael NL, Kim JH, Zolla-Pazner S, Haynes BF, Mascola JR, Self S, Gilbert P, Montefiori DC.

PLoS One. 2013 Sep 26;8(9):e75665. doi: 10.1371/journal.pone.0075665. eCollection 2013.

PMID:
24086607
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity.

van den Kerkhof TL, Feenstra KA, Euler Z, van Gils MJ, Rijsdijk LW, Boeser-Nunnink BD, Heringa J, Schuitemaker H, Sanders RW.

Retrovirology. 2013 Sep 23;10:102. doi: 10.1186/1742-4690-10-102.

PMID:
24059682
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Conservation, Compensation, and Evolution of N-Linked Glycans in the HIV-1 Group M Subtypes and Circulating Recombinant Forms.

Travers SA.

ISRN AIDS. 2012 Dec 19;2012:823605. doi: 10.5402/2012/823605. eCollection 2012.

PMID:
24052884
[PubMed]
Free PMC Article
20.

HIV-1 envelope glycoprotein resistance to monoclonal antibody 2G12 is subject-specific and context-dependent in macaques and humans.

Malherbe DC, Sanders RW, van Gils MJ, Park B, Gomes MM, Schuitemaker H, Barnett S, Haigwood NL.

PLoS One. 2013 Sep 9;8(9):e75277. doi: 10.1371/journal.pone.0075277. eCollection 2013.

PMID:
24040404
[PubMed - in process]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk